1. Articles from David Benoit and Kosaku Narioka

    1-1 of 1
    1. U.S. Activist Investor Takes Stake in Olympus

      U.S. Activist Investor Takes Stake in Olympus

      S ValueAct Capital Management LP made its first foray in Japan by taking a 5% stake in medical-device maker Olympus Corp. OCPNY 0.42% , the latest example of U.S.-based activist shareholders playing a bigger role in Asia. The ValueAct investment represents a bet that Olympus has room to increase its profit and win a higher valuation from investors...

      Read Full Article
    1-1 of 1
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics in the News

    1. (1 articles) JPMorgan
    2. (1 articles) Bloomberg
    3. (1 articles) ValueAct Capital
    4. (1 articles) KKR
    5. (1 articles) Medtronic
    6. (1 articles) Management
    7. (1 articles) Investors
    8. (1 articles) Investment
    9. (1 articles) Japan
    10. (1 articles) stake
    11. (1 articles) Corie Barry
    12. (1 articles) Yoshiaki Murakami
    13. (1 articles) Toshiba
    14. (1 articles) Best Buy
  3. Popular Articles

  4. Picture Gallery

    U.S. Activist Investor Takes Stake in Olympus Japan Activist Investor Yoshiaki Murakami Makes Surprise Bid to Disrupt Toshiba Deal Best Buy Board Investigates CEO Barry Over Allegation of Inappropriate Relationship Davos Elites Will Be Buzzing About Corporate Social Responsibility — and Its Limits Catalyst Biosciences Announces Addition of Geoffrey Shiu Fei Ling, M.D. and Sharon Tetlow to Board of Directors UMH Properties, Inc. Expands Board of Directors and Appoints New Member Airbnb Imagines a ‘Stakeholder’ World Activist Shareholder Group Sells Entire Primo Water Stake Tilson Appoints Sheryl Tullis to Board of Directors Metalla Strengthens Board of Directors The Rite Aid Board Prescription: Complete The Director Refill Q2Earth Appoints Douglas Baum, Senior Biosciences Executive, To Board of Directors